Contribution of the Ly49E Natural Killer Receptor in the Immune Response to Plasmodium berghei Infection and Control of Hepatic Parasite Development-Reference-Cited by-同舟云学术

Contribution of the Ly49E Natural Killer Receptor in the Immune Response to Plasmodium berghei Infection and Control of Hepatic Parasite Development

Published:2014-01-30 Issue:1 Volume:9 Page:e87463
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Filtjens Jessica,Foquet Lander,Taveirne Sylvie,Van Ammel Els,Vanhees Mandy,Van Acker Aline,Kerre Tessa,Taghon Tom,Vandekerckhove Bart,Plum Jean,Van den Steen Philippe E.,Leclercq Georges

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Public health challenges and prospects for malaria control and elimination;PL Alonso;Nat Med,2013

2. Malaria biology and disease pathogenesis: insights for new treatments;LH Miller;Nat Med,2013

3. Immune mechanisms in malaria: new insights in vaccine development;EM Riley;Nat Med,2013

4. NK cell responses to Plasmodium infection and control of intrahepatic parasite development;J Roland;J Immunol,2006

5. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection;K Mohan;J Immunol,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspecific binding of anti-NK1.1 antibodies on myeloid cells in an experimental model for malaria-associated acute respiratory distress syndrome;Malaria Journal;2024-04-18

2. Ly49E separates liver ILC1s into embryo-derived and postnatal subsets with different functions;Journal of Experimental Medicine;2022-03-29

3. NK Cells: Uncertain Allies against Malaria;Frontiers in Immunology;2017-03-09

4. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans;Proceedings of the National Academy of Sciences;2017-02-13

5. Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours;Scientific Reports;2016-07-29